Rekvina Laboratories Limited (BOM:526075)
35.45
+0.60 (1.72%)
At close: Mar 27, 2026
Rekvina Laboratories Market Cap
Rekvina Laboratories has a market cap or net worth of 213.69 million as of March 27, 2026. Its market cap has increased by 686.03% in one year.
Market Cap
213.69M
Enterprise Value
221.80M
Revenue
5.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.45
Market Cap Chart
Since July 26, 2013, Rekvina Laboratories's market cap has decreased from 443.60M to 213.69M, a decrease of -51.83%. That is a compound annual growth rate of -5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 213.69M | 687.78% |
| Dec 13, 2021 | 27.13M | 4.65% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Murae Organisor | 353.20M |
| Sandu Pharmaceuticals | 322.29M |
| Welcure Drugs and Pharmaceuticals | 308.99M |
| JFL Life Sciences | 292.01M |
| Gujarat Terce Laboratories | 257.58M |
| ANG Lifesciences India | 252.16M |
| Deccan Health Care | 171.47M |
| Add-Shop E-Retail | 171.29M |